181 related articles for article (PubMed ID: 37003989)
1. Progressive osseous heteroplasia in a 5-year-old boy with a novel mutation in exon 2 of GNAS: a case presentation and literature review.
Ma J; Mo W; Sun J; Li Y; Han T; Mao H
BMC Musculoskelet Disord; 2023 Mar; 24(1):247. PubMed ID: 37003989
[TBL] [Abstract][Full Text] [Related]
2. Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy.
Lin MH; Numbenjapon N; Germain-Lee EL; Pitukcheewanont P
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):911-8. PubMed ID: 25894639
[TBL] [Abstract][Full Text] [Related]
3. Mild progressive osseous heteroplasia overlap syndrome with PTH and TSH resistance appearing during adolescence and not early childhood.
Ozaki K; Mituboshi A; Nagai M; Nishiyama A; Nishimura G; Morisada N; Iijima K
Endocrine; 2021 Dec; 74(3):685-689. PubMed ID: 34254228
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification.
Adegbite NS; Xu M; Kaplan FS; Shore EM; Pignolo RJ
Am J Med Genet A; 2008 Jul; 146A(14):1788-96. PubMed ID: 18553568
[TBL] [Abstract][Full Text] [Related]
5. Endochondral ossification in a case of progressive osseous heteroplasia in a young female child.
Schrander DE; Welting TJ; Caron MM; Schrander JJ; van Rhijn LW; Körver-Keularts I; Schrander-Stumpel CT
J Pediatr Orthop B; 2014 Sep; 23(5):477-84. PubMed ID: 24626099
[TBL] [Abstract][Full Text] [Related]
6. Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series.
Elli FM; Barbieri AM; Bordogna P; Ferrari P; Bufo R; Ferrante E; Giardino E; Beck-Peccoz P; Spada A; Mantovani G
Bone; 2013 Oct; 56(2):276-80. PubMed ID: 23796510
[TBL] [Abstract][Full Text] [Related]
7. Progressive osseous heteroplasia is not a Mendelian trait but a type 2 segmental manifestation of GNAS inactivation disorders: A hypothesis.
Happle R
Eur J Med Genet; 2016 May; 59(5):290-4. PubMed ID: 27058263
[TBL] [Abstract][Full Text] [Related]
8. A Novel De Novo Frameshift Pathogenic Variant in the FAM111B Resulting in Progressive Osseous Heteroplasia Phenotype.
Ryabets-Lienhard A; Panjawatanan P; Vogt K; Ji J; Georgia S; Pitukcheewanont P
Calcif Tissue Int; 2023 Apr; 112(4):518-523. PubMed ID: 36575358
[TBL] [Abstract][Full Text] [Related]
9. Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report.
Gelfand IM; Hub RS; Shore EM; Kaplan FS; Dimeglio LA
Bone; 2007 May; 40(5):1425-8. PubMed ID: 17321228
[TBL] [Abstract][Full Text] [Related]
10. Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans.
Lebrun M; Richard N; Abeguilé G; David A; Coëslier Dieux A; Journel H; Lacombe D; Pinto G; Odent S; Salles JP; Taieb A; Gandon-Laloum S; Kottler ML
J Clin Endocrinol Metab; 2010 Jun; 95(6):3028-38. PubMed ID: 20427508
[TBL] [Abstract][Full Text] [Related]
11. GNAS-associated disorders of cutaneous ossification: two different clinical presentations.
Schimmel RJ; Pasmans SG; Xu M; Stadhouders-Keet SA; Shore EM; Kaplan FS; Wulffraat NM
Bone; 2010 Mar; 46(3):868-72. PubMed ID: 19900597
[TBL] [Abstract][Full Text] [Related]
12. Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLαs in fetal development.
Richard N; Molin A; Coudray N; Rault-Guillaume P; Jüppner H; Kottler ML
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1549-56. PubMed ID: 23884777
[TBL] [Abstract][Full Text] [Related]
13. A case report of mesenteric heterotopic ossification: Histopathologic and genetic findings.
Amalfitano M; Fyfe B; Thomas SV; Egan KP; Xu M; Smith AG; Kaplan FS; Shore EM; Pignolo RJ
Bone; 2018 Apr; 109():56-60. PubMed ID: 29320714
[TBL] [Abstract][Full Text] [Related]
14. A case of progressive osseous heteroplasia: a first case in Japan.
Kumagai K; Motomura K; Egashira M; Tomita M; Suzuki M; Uetani M; Shindo H
Skeletal Radiol; 2008 Jun; 37(6):563-7. PubMed ID: 18309480
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features, mutation of the GNAS1 and pathogenesis of progressive osseous heteroplasia].
Wu FQ; Wang L; Zou JZ; Huang XL; Yuan XY
Zhonghua Er Ke Za Zhi; 2012 Jan; 50(1):10-4. PubMed ID: 22456068
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the variety of GNAS inactivation disorders and their clinical manifestations in 11 Chinese children.
Chang G; Li Q; Li N; Li G; Li J; Ding Y; Huang X; Shen Y; Wang J; Wang X
BMC Endocr Disord; 2022 Mar; 22(1):70. PubMed ID: 35296306
[TBL] [Abstract][Full Text] [Related]
17. Progressive osseous heteroplasia caused by a mosaic GNAS mutation.
Pereda A; Martos-Tello JM; Garin I; Errea-Dorronsoro J; Perez de Nanclares G
Clin Endocrinol (Oxf); 2018 Jun; 88(6):993-995. PubMed ID: 29464731
[No Abstract] [Full Text] [Related]
18. GNAS mutations and heterotopic ossification.
Bastepe M
Bone; 2018 Apr; 109():80-85. PubMed ID: 28889026
[TBL] [Abstract][Full Text] [Related]
19. Progressive osseous heteroplasia.
Kaplan FS; Shore EM
J Bone Miner Res; 2000 Nov; 15(11):2084-94. PubMed ID: 11092391
[TBL] [Abstract][Full Text] [Related]
20. [Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
Kottler ML
Ann Endocrinol (Paris); 2015 May; 76(2):105-9. PubMed ID: 25952723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
